Sun Pharma signs US deal under MFN pricing to lower drug prices
Sun Pharmaceutical Industries signed a deal with the US government to lower prices of its innovative drugs in the US under the most favoured nation (MFN) pricing framework, aligned with the lowest prices paid by other developed nations.